Elekta’s Nomination Committee for the 2015 Annual General Meeting

STOCKHOLM, November 3, 2014 – In accordance with the resolution passed by
Elekta’s (EKTA-B.ST) Annual General Meeting on August 28, 2014, the Chairman of
the Board has contacted the company’s four largest shareholders in terms of
votes, in addition to the shareholder or shareholders represented by the
Chairman himself, each of whom expressed an interest in participating in the
Nomination Committee, and appointed one member (see below) to form Elekta’s
Nomination Committee together with the Chairman of the Board.
Nomination Committee members:

  · Laurent Leksell, in his capacity as Chairman of the Board of Elekta and
representing his own and related parties’ holdings
  · Åsa Nisell, appointed by Swedbank Robur funds
  · Jens Barnevik, appointed by Didner & Gerge Funds
  · Anders Oscarsson, appointed by AMF and AMF Funds
  · Ossian Ekdahl, appointed by the First Swedish National Pension Fund

The Nomination Committee will appoint one of its members as Chairman.

The Nomination Committee is tasked ahead of the 2015 Annual General Meeting with
preparing proposals pertaining to the number of Board members, Board fees, fees
for committee work, the composition of the Board, election of the Chairman of
the Board, election of the Chairman of the Annual General Meeting, auditors’
fees and election of auditors as well as guidelines for appointing the
Nomination Committee.

Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do
so by e-mail at valberedningen@elekta.com or by letter to:
Elekta AB, Nomination Committee
Box 7593
SE-103 93 Stockholm
Sweden

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 16:00 CET on November 3, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.